本文不构成任何投资意见和建议，以官方/公司公告为准；本文仅作医疗健康相关药物介绍，非治疗方案推荐（若涉及），不代表平台立场。任何文章转 载需得到授权。 2025年11月28日，江西富祥药业股份有限公司（股票代码：300497）与医药信息与人脉资源平台药融圈正式举行战略合作签约仪式，宣告双方未来将在医 药与生物制造领域深度融合，整合资源、技术与生态优势，共同推动技术创新与产业化提速，为医药健康产业高质量发展注入新动能。 随着生物医药技术的快速发展，合成蛋白作为替代传统蛋白获取方式的新兴技术，在医药健康、食品工业、新材料等领域展现出巨大潜力。 富祥药业凭借其在医药、生物制造等领域的深厚积累，已在微生物蛋白方向提前布局，旗下子公司富祥生物是国内首家新质蛋白吨级产业化企业，已建成 年产1200吨蛋白生产线。 （左：药融圈董事长王波 右：富祥药业执行总裁程健祖） 2025年11月27日，富祥药业已获得国家卫健委批文，对于富祥在生物制造领域的发展具备里程碑意义，同时能够推动国内食品制造业务，对国家粮食安全 亦具备积极作用。 富祥旗下有医药、新能源材料、生物制造三大产业。未来，双方将围绕富祥三大产业版块，深化在爆品打造、视 ...

Group 1 - The 2025 Biomanufacturing Industry Conference was held in Guangzhou, focusing on the development of the biomanufacturing industry and gathering various stakeholders including government officials, industry experts, and investors [1][2] - The biomanufacturing industry is identified as a strategic emerging industry in China's 14th Five-Year Plan, with a target of reaching a total output value of approximately 500 billion yuan by 2027 and aiming for a trillion yuan scale by 2035 [2][3] - Guangzhou has established a dedicated working group for biomanufacturing development, aiming to create a competitive biomanufacturing industry cluster by 2027, focusing on five key areas: biomedicine, biomaterials, biological food, biomedicine, and biological agriculture [2][3] Group 2 - Huangpu District and Guangzhou Development Zone are positioned as the core areas for biomanufacturing, with a comprehensive policy support system established to facilitate the entire chain from R&D to industrialization [3][4] - The Guangzhou Frontier Biotechnology and Biomanufacturing Innovation Promotion Center was officially inaugurated, aiming to create a collaborative innovation platform involving government, industry, academia, and research institutions [4][5] - The conference featured various sessions on topics such as "Pharmaceutical Health and Beauty," "Agriculture, Food, and Materials Industry," and "Artificial Intelligence and Biomanufacturing Innovation," highlighting the innovative achievements of local enterprises [5][6] Group 3 - Local companies like Chuang'er Biotechnology and Muen Biotechnology showcased their innovative products, with Chuang'er receiving regulatory approval for its collagen product and Muen being recognized for its extensive microbial library [5][6] - Guangzhou aims to position biomanufacturing as a strategic pillar for high-quality urban development, attracting global biotech companies and top talent to foster innovation and create a globally influential biomanufacturing innovation hub [6]

Core Insights - Guangdong aims to establish a trillion-yuan scale biomanufacturing industry cluster, with a focus on innovation and collaboration among government, industry, academia, and investment sectors [2][3]. Industry Development Goals - The "Action Plan for Accelerating the Construction of Biomanufacturing Industry Innovation High Ground" outlines a target of approximately 500 billion yuan in biomanufacturing output by 2027, progressing towards a trillion-yuan scale by 2035 [3]. - The biomanufacturing industry cluster is centered around Guangzhou and Shenzhen, with collaboration from cities like Zhuhai and Foshan [3]. Policy Initiatives - The upcoming "Several Measures to Promote Biomanufacturing Empowering Manufacturing Industry" will address issues such as incomplete industrial chains and lagging standard systems [4]. - Specific measures include establishing a comprehensive biomanufacturing standard system and supporting the formation of a standardization technical committee [4]. Innovation and Achievements - Local companies like Chuang'er Bio and Muen Bio have made significant advancements, with Chuang'er's collagen product receiving regulatory approval and Muen's microbial protein achieving GRAS certification in the U.S. [5]. - These innovations highlight Guangzhou's strong capabilities in biomanufacturing [5]. Infrastructure and Research Support - Guangzhou has integrated biomanufacturing into its "12218" modern industrial system, aiming to create a nationally competitive industry cluster by 2027 [6]. - The establishment of the Guangzhou Frontier Biotechnology and Biomanufacturing Innovation Promotion Center aims to facilitate the commercialization of research outcomes and enhance talent development [7][8].